Molecular Formula | C17H17N3O2HCl |
Molar Mass | 331.8 |
Solubility | H2O: soluble22mg/mL |
Appearance | White solid |
Color | white to yellow |
Storage Condition | Keep in dark place,Inert atmosphere,Store in freezer, under -20°C |
Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or distilled water may be stored at -20° for up to 3 months. |
Sensitive | Light Sensitive & Hygroscopic |
Use | PJ34 HCl is a hydrochloride form of PJ34 and is a PARP inhibitor with EC50 of 20 nM, which is equally effective on PARP1/2. |
In vitro study | PJ34 inhibits the PARP enzyme activity with an IC 50 of 110±1.9 nM. To compare the neuroprotective properties of other PARP inhibitors in PC12 cells, PJ34 is evaluated using by LDH assay. PJ34 treatment also significantly and concentration dependently attenuates cell death at a concentration ranging from 10 -7 to 10 -5 M. |
In vivo study | To compare the potency and efficacy with other PARP inhibitors, PJ34 is evaluated at the doses of 3.2 and 10 mg/kg, respectively. PJ34 at the dose of 3.2 mg/kg significantly reduces cortical damage by 33%; however, 10 mg/kg dosing shows reversed effect (17% reduction). PJ34 (25 mg/kg) reduces the levels of TNF-α mRNA in ischemic animals by 70% and these values in treated mice do not differ from that of sham or naive animals. Treatment of ischemic mice with PJ34 reduces the level of E-selectin mRNA by 81% and that of ICAM-1 mRNA by 54%, compared to vehicle-treated ischemic mice. |
Safety Description | S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. |
WGK Germany | 3 |
HS Code | 29339900 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.014 ml | 15.069 ml | 30.139 ml |
5 mM | 0.603 ml | 3.014 ml | 6.028 ml |
10 mM | 0.301 ml | 1.507 ml | 3.014 ml |
5 mM | 0.06 ml | 0.301 ml | 0.603 ml |
biological activity | PJ34 hydrochloride is an inhibitor of PARP1/2 with IC50 values of 110 nM and 86 nM, respectively. |